Takeaways
#- Strazza saw overseas relative momentum as a possible early signal of a larger trend reversal.
- He allowed for a short- or intermediate-term pause after the initial thrust.
- The dollar-rotation explanation remained a hypothesis; U.S. support and follow-through drove the trading decisions.
- DePablos identified healthcare as a growing source of domestic leadership.
A sharp relative move in developed overseas stocks caught Steve Strazza’s attention on the March 7, 2025 Morning Show. He regarded it as a possible early signal of a larger reversal after years of U.S. leadership. That did not make him comfortable ignoring the deterioration in U.S. charts.
JC Parets approached the same divergence from a global perspective. Strength in Europe, China and Hong Kong gave him reasons to keep looking for places to put money to work, even as American stocks struggled.
A momentum thrust could precede a long pause
Strazza described the relative move as starting-line momentum: a large initial change that could help establish a new trend. The comparison involved EAFE, the developed-market universe outside the United States and Canada, against U.S. stocks.
The week was not finished. The hosts explicitly distinguished the calendar-week reading they were discussing from a rolling five-day calculation, and Friday’s session still remained.
Strazza also separated the longer-term signal from the immediate trade. A strong thrust could be constructive for a primary trend while leaving the following weeks or months neutral or weak. He compared the situation with China’s sharp move the previous fall and the period of frustration that followed before its more recent strength.
He wanted the relative chart to build a base and its 200-day moving average to flatten and turn higher. The thrust increased his confidence in that possibility; the rest of the reversal still had to develop.
Dollar weakness did not erase weak U.S. price action
Parets wondered whether the dollar’s rapid decline was encouraging such a strong move overseas that investors were selling liquid U.S. stocks to finance it. He framed that as a question about the rotation, not as a measured flow calculation.
Strazza was less interested in choosing the explanation. Whether the selling reflected profit-taking or international reallocation would not change what he needed to do with a deteriorating U.S. position. He also noted that U.S. stocks had responded differently during the earlier period of pronounced dollar weakness in late 2022.
For Parets, the international comparison helped answer a broader allocation question. A U.S. decline occurring alongside strength elsewhere looked different from risk assets falling together around the world.
U.S. support still needed follow-through
Later in the broadcast, Strazza walked through major indexes approaching combinations of anchored volume-weighted average prices and Fibonacci retracements. He saw several charts reaching support that had mattered during the advance from the prior year’s lows.
Holding those zones could leave the uptrends intact and create opportunities on the long side. Breaking them would make him interested in shorting groups such as banks and homebuilders. He wanted follow-through early the next week rather than assuming Friday alone would resolve the question.
He had already bought calls in Lennar and PulteGroup after seeing constructive price action in homebuilders. He was willing to trade a failure in the other direction, too. He considered semiconductor strength particularly important to the larger market and was less willing to excuse persistent weakness there.
Healthcare names were moving up the rankings
Alfonso DePablos joined to discuss the large companies appearing in his domestic and international scans. Overseas financials remained prominent, and he was seeing more of that strength rather than a completely new set of leading industries.
The clearer change in the United States was healthcare. He identified Gilead Sciences and Bristol Myers Squibb as improving names, alongside strength in McKesson and AbbVie. Those companies were moving toward the top of his scans as many of the familiar growth leaders struggled.
Questions and answers
#Questions answered in the original 2025-03-07 episode.
Why could a bullish momentum thrust still be followed by weakness?
Strazza treated it as a longer-term indication of a potential trend change. He allowed for the initial surge to unwind or pause before the relative trend developed further.
What did Strazza want to see from U.S. support?
He wanted indexes to hold the zones where anchored VWAPs and retracements converged, followed by constructive action early the next week.
Which U.S. sector was improving in DePablos’s scans?
Healthcare. He discussed Gilead Sciences, Bristol Myers Squibb, McKesson and AbbVie as names showing strength or moving up his rankings.
Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .